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The prevalence of non-communicable diseases in South Africa (SA) 
is increasing. Alarmingly, SA is one of the nations with the most 
obese people in the world.[1-3] The incidence of gestational diabetes 
mellitus (GDM) is similarly increasing. However, while healthcare 
policies focus on communicable and non-communicable diseases, 
advocacy for screening, immediate and long-term management and 
follow-up of GDM are lacking.
GDM is associated with adverse maternal and perinatal outcomes 
if undetected and untreated. Furthermore, the fetal programming 
theory demonstrates that offspring of diabetic mothers (including 
mothers with GDM) are at increased risk of obesity and metabolic 
syndrome during childhood and later in life.[4,5] Women with GDM 
have an increased risk of developing type 2 diabetes within 10 years.[6] 
Observational studies have noted that partners of women with GDM 
are also more likely to be obese and at risk of metabolic diseases.[7]
The screening and management of GDM are cost effective if coupled 
with postpartum follow-up and lifestyle modification, resulting in 
lower rates of non-communicable diseases later in life. The latest 
guidelines for GDM screening by the International Association of 
Diabetes in Pregnancy Study Groups (IADPSG) were based on the 
Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study 
data. HAPO did not demonstrate a clear inflection point above which 
the risk of adverse outcomes increases. Rather, hyperglycaemia-
associated adverse outcomes increase along a continuum. The 
IADPSG recommendations are based on a 1.75 odds ratio of 
developing adverse outcomes. These glucose thresholds are low and 
have been criticised for increasing the number of women with GDM, 
thus increasing workload and cost.[8] The Society for Endocrinology, 
Metabolism, and Diabetes of South Africa (SEMDSA) endorsed 
these guidelines in 2017.[9] However, little consideration was given to 
implementation, effect on cost, workload, follow-up or management 
of women with GDM. Consequently, the screening and management 
of GDM are sporadic and inconsistent among the different healthcare 
facilities and provinces in SA.
The IADPSG was formed in 1998 as an umbrella organisation 
to facilitate collaboration between various regional and national 
organisations that focus on diabetes in pregnancy. Their principal 
objective is to foster an international approach to enhancing the 
quality of care, facilitating research and advancing education in the 
field of diabetes in pregnancy.[10] 
SA could benefit from forming an association of diabetes-in-pregnancy 
study group, comprising interested obstetricians, diabetologists, 
endocrinologists, dieticians, public health specialists and scientists. 
Pooling knowledge and experience, and research collaboration in 
the SA context, can lead to more appropriate national screening and 
management policies. The IADPSG provides for screening strategies in 
low- and middle-income countries such as India and China. SA, which 
has many similar challenges, can share experiences and thus extrapolate 
appropriate achievable recommendations based on SA research and 
international experience if affiliated to the IADPSG. The IADPSG also 
investigates alternative, less cumbersome screening strategies for GDM. 
While such research is ongoing in SA, local researchers can benefit from 
international collaboration.
Hence, the formation of an SA association of diabetes-in-pregnancy 
study group affiliated to the IADPSG has multiple potential benefits:
• collaborative, co-operative research in SA to address prevalence, 
role of risk factors, on-site training, diagnostic thresholds, thera-
peutic strategies
• appropriate follow-up of postpartum women and early detection of 
type 2 diabetes in women with GDM
• investigation of potential early or novel markers for diagnosis of 
GDM
• follow-up of children of mothers with GDM for obesity, metabolic 
risk and glycaemic control
• collaboration with public health specialists
• evaluation of the cost-effectiveness of screening and management 
of GDM patients
• creation of viable implementation policies so that all pregnant 
women regardless of location receive the same level of care.
SA is faced with a dual burden of disease. While diabetes mellitus has 
gained more attention, GDM is largely ignored. Conditions such as 
pre-eclampsia and obstetric haemorrhage are a major focus in obstet-
ric care – understandably so, as they cause maternal mortality. However, 
if we do not acknowledge the increasing prevalence of GDM we shall 
be creating a future generation of obese, sick individuals who overburden 
the healthcare system. Prevention is better than management, and a 
good way to protect future generations is 
to identify at-risk individuals as early as 
possible (even in utero) and implement 
life style programmes to prevent future 
disease epidemics.[11]
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